StockData
Herbalife Ltd. logo

Herbalife Ltd. (HLF) stock

HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3041% below fair value
$16.04+0.47 (+3.02%)

Close on Nov 18, 2026Market cap $1.68BP/E 10.3Yield –

Herbalife operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Herbalife's operating income for the twelve months ending Jun 30, 2026 was $492.30M, up 0.7% year over year. For fiscal 2025 it was $481.00M, up 24.6% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $735.30M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$481.00M+24.6%
FY2024Dec 31, 2024$385.90M+8.3%
FY2023Dec 31, 2023$356.40M-34.6%
FY2022Dec 31, 2022$545.20M-25.7%
FY2021Dec 31, 2021$734.10M+14.6%
FY2020Dec 31, 2020$640.60M+12.8%
FY2019Dec 31, 2019$568.10M-16.8%
FY2018Dec 31, 2018$683.10M+10.7%
FY2017Dec 31, 2017$617.10M+34.7%
FY2016Dec 31, 2016$458.10M-21.5%
FY2015Dec 31, 2015$583.60M+13.7%
FY2014Dec 31, 2014$513.50M-30.2%
FY2013Dec 31, 2013$735.30M+11.2%
FY2012Dec 31, 2012$661.40M+17.6%
FY2011Dec 31, 2011$562.27M+45.1%
FY2010Dec 31, 2010$387.51M+30.9%
FY2009Dec 31, 2009$296.03M-10.9%
FY2008Dec 31, 2008$332.25M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$128.30M-3.2%
Q1 FY2026Mar 31, 2026$138.40M+12.7%
Q4 FY2025Dec 31, 2025$99.80M-6.3%
Q3 FY2025Sep 30, 2025$125.80M-1.0%
Q2 FY2025Jun 30, 2025$132.60M+64.9%
Q1 FY2025Mar 31, 2025$122.80M+70.8%
Q4 FY2024Dec 31, 2024$106.50M+90.9%
Q3 FY2024Sep 30, 2024$127.10M+19.1%
Q2 FY2024Jun 30, 2024$80.40M-34.8%
Q1 FY2024Mar 31, 2024$71.90M+2.0%
Q4 FY2023Dec 31, 2023$55.80M-37.2%
Q3 FY2023Sep 30, 2023$106.70M-27.6%
Q2 FY2023Jun 30, 2023$123.40M-20.8%
Q1 FY2023Mar 31, 2023$70.50M-54.0%
Q4 FY2022Dec 31, 2022$88.90M+5.5%
Q3 FY2022Sep 30, 2022$147.40M-22.2%
Q2 FY2022Jun 30, 2022$155.80M-34.5%
Q1 FY2022Mar 31, 2022$153.10M-31.2%
Q4 FY2021Dec 31, 2021$84.30M-43.2%
Q3 FY2021Sep 30, 2021$189.40M-8.5%
Q2 FY2021Jun 30, 2021$237.90M+25.4%
Q1 FY2021Mar 31, 2021$222.50M+132.7%
Q4 FY2020Dec 31, 2020$148.40M+36.9%
Q3 FY2020Sep 30, 2020$206.90M+44.1%
Q2 FY2020Jun 30, 2020$189.70M+23.9%
Q1 FY2020Mar 31, 2020$95.60M-41.3%
Q4 FY2019Dec 31, 2019$108.40M-26.9%
Q3 FY2019Sep 30, 2019$143.60M-23.3%
Q2 FY2019Jun 30, 2019$153.10M-20.2%
Q1 FY2019Mar 31, 2019$163.00M+4.6%
Q4 FY2018Dec 31, 2018$148.20M-0.6%
Q3 FY2018Sep 30, 2018$187.30M+57.0%
Q2 FY2018Jun 30, 2018$191.80M-6.4%
Q1 FY2018Mar 31, 2018$155.80M+8.3%
Q4 FY2017Dec 31, 2017$149.10M-5.8%
Q3 FY2017Sep 30, 2017$119.30M-21.3%
Q2 FY2017Jun 30, 2017$204.90M–
Q1 FY2017Mar 31, 2017$143.80M–
Q4 FY2016Dec 31, 2016$158.20M–
Q3 FY2016Sep 30, 2016$151.50M–

More Herbalife figures

See a number that looks wrong?